Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: Report of one case

Acta Paediatrica Taiwanica

Volumn 47, Issue 3, 2006, Pages 150-154

  Yu, Hsin Hui ^a   Lu, Meng Yao ^a   Lin, Dong Tsamn ^a   Lin, Kai Hsin ^a   Tang, Jih Luh ^a   Jou, Shiann Tarng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic myelogenous leukemia; Extramedullary blastic crisis; Fracture; Imatinib mesylate

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; BLAST CELL CRISIS; BONE LESION; BONE MARROW; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; FEMALE; FEMUR FRACTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; PRESCHOOL CHILD;

BLAST CRISIS; CHILD, PRESCHOOL; FEMALE; FEMORAL FRACTURES; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PYRIMIDINES;

EID: 33751252010     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rowe JM, Lichtman MA. Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood 1984; 63:1230-4.
2. Castro-Malaspina H, Schaison G, Briere J, et al. Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors. Cancer 1983; 52:721-7.
3. Sawyers CL. Chronic myeloid leukemia. N Engl J Med 1999; 340:1330-40.
4. Kantarjian HM, Keating MJ, Talpaz M, et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 1987; 83:445-54.
5. Sacchi S, Kantarjian HM, O'Brien S, et al. Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients. Cancer 1999; 86:2632-41.
6. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247:824-30.
7. Specchia G, Palumbo G, Pastore D, Mininni D, Mestice A, Liso V. Extramedullary blast crisis in chronic myeloid leukemia. Leuk Res 1996; 20:905-8
8. Terjanian T, Kantarjian H, Keating M, Talpaz M, McCredie K, Freireich EJ. Clinical and prognostic features of patients with Philadelphia chromosome-positive chronic myelogenous leukemia and extramedullary disease. Cancer 1987; 59:297-300.
9. Maloisel F, Favre G, Mahmal L, Zamfir A, Andres E. Isolated lytic bone lesion as extramedullary disease in chronic myelogenous leukemia: a report of three new cases. Eur J Intern Med 2005; 16:288-90.
10. Millot F, Guilhot J, Nelken B, et al. Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation. Leukemia 2006; 20:187-92.
11. Chabner BA, Haskell CM, Canellos GP. Destructive bone lesion in chronic granulocytic leukemia. Medicine 1969; 48:401-10.
12. Turner RM, Peck WW, Prietto C. MR of sott tissue chloroma in a patient presenting with left pubic and hip pain. Journal of Computer Assisted Tomography 1991; 15:700-2.
13. Schabel ST, Tyminski L, Hollang RD. The skeletal manifestations of chronic myelogenous leukemia. Skeletal Radiology 1980; 5:145-9.
14. Libson E, Bloom RA, Galun E. Granulocytic sarcoma (chloroma) of bone: the CT appearance. Computerized Radiology 1986; 10:175-8.
15. Spengler DM, Leiberg OU, Bailey RW. Rapid Diaphyseal destruction An unusual osseous manifestation of chronic granulocytic leukemia. Clinical Orthopaedics and related research 1976; 115:231-5.
16. Oppermann HC, Ludwig R, George P. Osteolytic lesion in chronic myelogenous leukemia (CML). Initial manifestation of blastic crisis? Pediatric Radiology 1979; 8:254-6.
17. Tricot G., Boogaerts MA, Broeckaert-van orshoven A. Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia. Cancer 1983; 52:841-5.
18. Kubota K, Yanagisawa T. Kurabayashi H. Hypercalcemia associated with osteolytic lesions in the extramedullary blastic crisis of chronic myelogenous leukemia: report of a case. Blut 1989; 59:458-9.
19. Manoharan A, Phadke KP, Leyden MJ. Osteolytic lesions in chronic myelogenous leukemia. Aust N Z J Med 1979; 9:87-8.
20. Nadal E, Cervantes F, Rosinol L, Talarn C, Montserrat E. Hypercalcemia as the presenting feature of t-cell lymphoid blast crisis of ph-positive chronic myeloid leukemia. Leuk Lymphoma 2001; 41:203-6.
21. Valimaki M, Vuopio P, Liewendahl K. Bone lesions in chronic myelogenous leukemia. Acta Medica Scandinavica 1981; 210:403-8.
22. Kantarjian HM, Cortes J, O'Brien S, et al. Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Blood 2002; 99:3547-53.
23. Naito K, Mori T, Miyazaki K, Tsukada Y, Ikeda Y, Okamoto S. Successful treatment of extramedullary blast crisis of chronic myelogenous leukemia with imatinib mesylate (STI571). Intern Med 2003; 42:740-2.